Already a member? Sign in
Category: Prescription Drugs
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant used in the treatment of depression as well as anxiety disorders.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Depressed mood | 321 | 78 |
|
|
|
|
|
| Anxious mood | 149 | 40 |
|
|
|
|
|
| Treat my mood condition(s) | 98 | 30 |
|
|
|
|
|
| Social Anxiety Disorder | 63 | 8 |
|
|
|
||
| Panic attacks | 36 | 16 |
|
|
|
|
|
| Other | 32 | 7 |
|
|
See all 666 patients currently taking Paroxetine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Paroxetine
| Weight gain | 22 | |
|---|---|---|
| Sexual dysfunction | 21 | |
| Agitation | 14 | |
| Brain fog | 14 | |
| Sex drive (libido) decreased | 13 | |
| Insomnia | 13 | |
| See all 97 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Paroxetine. See all 34 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 105 | ||
| Side effects too severe | 102 | ||
| Doctor's advice | 71 | ||
| Other | 52 | ||
| Personal research | 24 | ||
| Expense | 15 | ||
| Course of treatment ended | 14 | ||
| Change in health plan coverage | 5 | ||
| Not indicated | 2 |
Adherence
Taking treatment as prescribed
Adherence of Paroxetine
Always |
167 | 77% |
|
|---|---|---|---|
Usually |
32 | 15% |
|
Sometimes |
8 | 4% |
|
Never |
9 | 4% |
|
Burden
Difficulty being on treatment
Burden of Paroxetine
Very |
13 | 6% |
|
|---|---|---|---|
Somewhat |
18 | 8% |
|
A little |
41 | 19% |
|
Not at all |
144 | 67% |
|
Cost
Paid out of pocket
Cost of Paroxetine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 1% |
|
$50-99 |
9 | 6% |
|
$25-49 |
24 | 17% |
|
< $25 |
108 | 76% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 09, 2012.